Literature DB >> 25018661

Carboxylesterases: Dual roles in lipid and pesticide metabolism.

Matthew K Ross1, Timothy M Streit1, Katye L Herring1.   

Abstract

Carboxylesterases (CES, EC 3.1.1.1) are members of a superfamily of serine hydrolases that hydrolyze ester, amide, and carbamate bonds. Several different CES genes exist in mammalian species with evidence of multiple gene duplication events occurring throughout evolutionary history. There are five CES genes reported in the Human Genome Organization database, although CES1 and CES2 are the two best characterized human genes. An emerging picture of the CES family suggests that these enzymes have dual roles in the metabolism of xenobiotic and endobiotic compounds. Pesticides, such as the pyrethroids, are important xenobiotic substrates that are metabolized by CES, whereas cholesteryl esters, triacylglycerols, and 2-arachidonoylglycerol are examples of endobiotics known to be substrates for CES. Functional studies using selective chemical inhibitors, siRNA, and gene knockout models are providing valuable insights into the physiological functions of CES, and suggest that CES may be a novel target for the treatment of diseases such as diabetes and atherosclerosis. This review will examine the known physiological functions of CES, the interactions between xenobiotics (primarily pesticides) and lipids that occur with CES enzymes, and where possible the implications that these findings may have in terms of health and disease.

Entities:  

Keywords:  carboxylesterase; cholesteryl ester hydrolase; macrophage; organophosphates; pyrethroids; xenobiotic biotransformation

Year:  2010        PMID: 25018661      PMCID: PMC4087164          DOI: 10.1584/jpestics.R10-07

Source DB:  PubMed          Journal:  J Pestic Sci        ISSN: 1348-589X            Impact factor:   1.519


  69 in total

Review 1.  Enzymes with extra talents: moonlighting functions and catalytic promiscuity.

Authors:  Shelley D Copley
Journal:  Curr Opin Chem Biol       Date:  2003-04       Impact factor: 8.822

2.  Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

Authors:  Sabine Steffens; Niels R Veillard; Claire Arnaud; Graziano Pelli; Fabienne Burger; Christian Staub; Meliha Karsak; Andreas Zimmer; Jean-Louis Frossard; François Mach
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

3.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Identification of rat and human cytochrome p450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides deltamethrin and esfenvalerate.

Authors:  Stephen J Godin; J Allen Crow; Edward J Scollon; Michael F Hughes; Michael J DeVito; Matthew K Ross
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

5.  Pathogenesis of cholesteryl lipidosis of adrenocortical and ovarian interstitial cells in F344 rats caused by tricresyl phosphate and butylated triphenyl phosphate.

Authors:  J R Latendresse; S Azhar; C L Brooks; C C Capen
Journal:  Toxicol Appl Pharmacol       Date:  1993-10       Impact factor: 4.219

6.  Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice.

Authors:  Bin Zhao; Jingmei Song; Woon N Chow; Richard W St Clair; Lawrence L Rudel; Shobha Ghosh
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes.

Authors:  Parikshit C Das; Timothy M Streit; Yan Cao; Randy L Rose; Nathan Cherrington; Matthew K Ross; Andrew D Wallace; Ernest Hodgson
Journal:  Drug Metabol Drug Interact       Date:  2008

8.  Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice.

Authors:  Frédérique Dol-Gleizes; Réjane Paumelle; Virgile Visentin; Anne-Marie Marés; Perrine Desitter; Nathalie Hennuyer; Andries Gilde; Bart Staels; Paul Schaeffer; Françoise Bono
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-09       Impact factor: 8.311

Review 9.  Genomic structure and transcriptional regulation of the rat, mouse, and human carboxylesterase genes.

Authors:  Masakiyo Hosokawa; Tomomi Furihata; Yumiko Yaginuma; Naoko Yamamoto; Nao Koyano; Ayako Fujii; Yuko Nagahara; Testuo Satoh; Kan Chiba
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

Review 10.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation.

Authors:  Takao Shimizu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2009       Impact factor: 13.820

View more
  17 in total

Review 1.  Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.

Authors:  Lucy Her; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2019-12-23       Impact factor: 3.922

2.  Examination of the carboxylesterase phenotype in human liver.

Authors:  Matthew K Ross; Abdolsamad Borazjani; Ran Wang; J Allen Crow; Shuqi Xie
Journal:  Arch Biochem Biophys       Date:  2012-04-16       Impact factor: 4.013

3.  Effects of chlorpyrifos on non-cholinergic toxicity endpoints in immortalized and primary rat hepatocytes under normal and hepatosteatotic conditions.

Authors:  SandeepReddy Kondakala; Lucie Henein; Erin McDevitt; Matthew K Ross; George Eli Howell
Journal:  Toxicol In Vitro       Date:  2022-02-11       Impact factor: 3.500

4.  Carboxylesterase 1d Inactivation Augments Lung Inflammation in Mice.

Authors:  Brittany N Szafran; Abdolsamad Borazjani; Hannah L Scheaffer; J Allen Crow; Ann Marie McBride; Oluwabori Adekanye; Caitlin B Wonnacott; Richard Lehner; Barbara L F Kaplan; Matthew K Ross
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-12

5.  Development of amide-based fluorescent probes for selective measurement of carboxylesterase 1 activity in tissue extracts.

Authors:  Sean D Kodani; Morgane Barthélemy; Shizuo G Kamita; Bruce Hammock; Christophe Morisseau
Journal:  Anal Biochem       Date:  2017-10-18       Impact factor: 3.365

6.  Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1(+/-)/Akt2(-/-) mice.

Authors:  Brian A Pedersen; Weiwen Wang; Jared F Taylor; Omar S Khattab; Yu-Han Chen; Robert A Edwards; Puya G Yazdi; Ping H Wang
Journal:  Metabolism       Date:  2015-09-12       Impact factor: 8.694

7.  Effects of Chlorpyrifos on Serine Hydrolase Activities, Lipid Mediators, and Immune Responses in Lungs of Neonatal and Adult Mice.

Authors:  Brittany N Szafran; Abdolsamad Borazjani; Caitlin N Seay; Russell L Carr; Richard Lehner; Barbara L F Kaplan; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2021-04-26       Impact factor: 3.973

8.  Profiling of MicroRNA Targets Using Activity-Based Protein Profiling: Linking Enzyme Activity to MicroRNA-185 Function.

Authors:  Roxana Filip; Geneviève F Desrochers; David M Lefebvre; Alex Reed; Ragunath Singaravelu; Benjamin F Cravatt; John Paul Pezacki
Journal:  Cell Chem Biol       Date:  2021-01-14       Impact factor: 9.039

9.  Comparative transcriptome analysis of salivary glands of two populations of rice brown planthopper, Nilaparvata lugens, that differ in virulence.

Authors:  Rui Ji; Haixin Yu; Qiang Fu; Hongdan Chen; Wenfeng Ye; Shaohui Li; Yonggen Lou
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

10.  Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate.

Authors:  Rima Kaddurah-Daouk; Thomas Hankemeier; Elizabeth H Scholl; Rebecca Baillie; Amy Harms; Claus Stage; Kim P Dalhoff; Gesche Jűrgens; Olivier Taboureau; Grace S Nzabonimpa; Alison A Motsinger-Reif; Ragnar Thomsen; Kristian Linnet; Henrik B Rasmussen
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.